Dose-adjusted EPOCH-rituximab or intensified B-NHL therapy for pediatric primary mediastinal large B-cell lymphoma

• Fabian Knörr,
• Martin Zimmermann,
• Andishe Attarbaschi,
• Edita Kabíčková,
• Britta Maecker-Kolhoff,
• Stephanie Ruf,
• Ingrid Kühnle,
• Martin Ebinger,
• Anne-Kathrin Garthe,
• Ingrid Simonitsch-Klupp,
• Ilske Oschlies,
• Wolfram Klapper,
• Birgit Burkhardt,
• Wilhelm Woessmann

Affiliations

Fabian Knörr

UKE, Department of Pediatric Hematology and Oncology, Hamburg

Martin Zimmermann

Hannover Medical School, Clinic for Pediatric Hematology and Oncology, Hannover

Andishe Attarbaschi

St. Anna Children’s Hospital, Medical University of Vienna, Department of Pediatric Hematology and Oncology, Vienna

Edita Kabíčková

Charles University and University Hospital Motol, Department of Pediatric Hematology and Oncology, Prague, Czech Republic

Britta Maecker-Kolhoff

Hannover Medical School, Clinic for Pediatric Hematology and Oncology, Hannover

Stephanie Ruf

University of Gießen, Pediatric Hematology and Oncology, Gießen

Ingrid Kühnle

University Medical Center Göttingen, Division of Pediatric Hematology and Oncology, Göttingen

Martin Ebinger

Children's University Hospital Tübingen, Department of General Pediatrics and Pediatric Hematology/Oncology, Tübingen

Anne-Kathrin Garthe

University-Hospital of Münster, Pediatric Hematology and Oncology, Münster

Ingrid Simonitsch-Klupp

Clinical Institute of Pathology, Medical University of Vienna, Vienna

Ilske Oschlies

Universitätsklinikum Schleswig-Holstein, Campus Kiel, Institute of Pathology, Hematopathology Section and Lymph Node Registry, Kiel

Wolfram Klapper

Universitätsklinikum Schleswig-Holstein, Campus Kiel, Institute of Pathology, Hematopathology Section and Lymph Node Registry, Kiel

Birgit Burkhardt

University-Hospital of Münster, Pediatric Hematology and Oncology, Münster

Wilhelm Woessmann

UKE, Department of Pediatric Hematology and Oncology, Hamburg